Mark Heinen - Net Worth and Insider Trading

Mark Heinen Net Worth

The estimated net worth of Mark Heinen is at least $694 dollars as of 2024-06-10. Mark Heinen is the See Remarks of Better Therapeutics Inc and owns about 72,281 shares of Better Therapeutics Inc (BTTX) stock worth over $694. Details can be seen in Mark Heinen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Heinen has not made any transactions after 2022-09-13 and currently still holds the listed stock(s).

Transaction Summary of Mark Heinen

To

Mark Heinen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Heinen owns 2 companies in total, including Better Therapeutics Inc (BTTX) , and Mountain Crest Acquisition Corp II (MCADU) .

Click here to see the complete history of Mark Heinen’s form 4 insider trades.

Insider Ownership Summary of Mark Heinen

Ticker Comapny Transaction Date Type of Owner
BTTX Better Therapeutics Inc 2022-09-13 See Remarks
MCADU Mountain Crest Acquisition Corp II 2021-10-28 See Remarks

Mark Heinen Latest Holdings Summary

Mark Heinen currently owns a total of 1 stock. Mark Heinen owns 72,281 shares of Better Therapeutics Inc (BTTX) as of September 13, 2022, with a value of $694.

Latest Holdings of Mark Heinen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BTTX Better Therapeutics Inc 2022-09-13 72,281 0.01 694

Holding Weightings of Mark Heinen


Mark Heinen Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Heinen has made a total of 4 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 50,000 shares on September 13, 2022, which cost Mark Heinen around $97,000.

Insider Trading History of Mark Heinen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Heinen Trading Performance

GuruFocus tracks the stock performance after each of Mark Heinen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Heinen is -7.85%. GuruFocus also compares Mark Heinen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Heinen within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark Heinen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark Heinen

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.14 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.53 LIMIT LIMIT LIMIT LIMIT LIMIT

Mark Heinen Ownership Network

Ownership Network List of Mark Heinen

No Data

Ownership Network Relation of Mark Heinen

Insider Network Chart

Mark Heinen Owned Company Details

What does Better Therapeutics Inc do?

Who are the key executives at Better Therapeutics Inc?

Mark Heinen is the See Remarks of Better Therapeutics Inc. Other key executives at Better Therapeutics Inc include director & See Remarks Frank Karbe , director & 10 percent owner & See Remarks David P Perry , and Chief Medical Officer Mark A. Berman .

Better Therapeutics Inc (BTTX) Insider Trades Summary

Over the past 18 months, Mark Heinen made no insider transaction in Better Therapeutics Inc (BTTX). Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 6,202,742 shares made by David P Perry , a net purchase of 988,055 shares made by Geoffrey M. Parker , and a net purchase of 577,040 shares made by Andrew J. Armanino .

In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 8,236,919 shares were bought by its insiders, resulting in a net purchase of 8,236,919 shares.

Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Better Therapeutics Inc Insider Transactions

No Available Data

Mark Heinen Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Heinen. You might contact Mark Heinen via mailing address: 548 Market Street, #49404, San Francisco Ca 94104.

Discussions on Mark Heinen

No discussions yet.